According to the report published by the Market Research Store, global demand for the leukapheresis market was estimated at approximately USD 94.7 Million in 2020 and is expected to generate revenue of around USD 580.1 Million by the end of 2026, growing at a CAGR of around 38.6% between 2021 and 2026.

Global Leukapheresis Market: Overview

Leukapheresis is a type of specifically modified apheresis procedure intended to take away leukocytes and return the residual cells such as the red blood cells, platelets, and granulocytes to the donor. In addition, the leukopaks (LPs) are leukapheresis samples taken from healthy peripheral blood. Leukapheresis is alike to apheresis where the red blood cells or platelets are extracted from blood, and the residual blood is sent to the body’s blood circulation. The separation of white blood cells from the sample of blood, which is occupied with the immune system of the body, is completed with a medical process, described as leukapheresis. The body’s high white blood cells could result in chronic blood cancers such as chronic lymphocytic leukemia (CLL), and hence leukapheresis is significant to be executed.

REPORT SNAPSHOT & REPORTING DATA TIMEFRAME
Parameter Details
Historical Date ( Actual Data) 2016 - 2020
Base Year Data 2020
Current Year Data 2021
Projected Data 2021 - 2026
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered product type, application, region
Regional scope North America; Europe; Asia Pacific; Central & South America; Middle East & Africa
Country Scope U.S.; Canada; Mexico; Germany; France; U.K.; China; Japan; South Korea; Singapore; Malaysia; Brazil; Saudi Arabia
Customization scope Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options Avail customized purchase options to meet your exact research needs. Explore purchase options

Global Leukapheresis Market: Growth Factor

Significant factors fuelling the growth of the global leukapheresis market are the growing occurrence and prevalence of leukemia and the increasing demand for leukopaks for research applications.

However, the severe donor recruitment criteria, the high expenditure of cellular therapies and therapeutic leukapheresis, and the long procedural time for leukapheresis are some aspects that might hamper the market growth in the global leukapheresis to a certain level. Additionally, trained and skillful physicians or nurses are also needed for efficient treatment and the collection or removal of white blood cells using apheresis. This factor makes leukapheresis a costly device for temporary use. Conversely, the applications of therapeutic leukapheresis in pediatric patient treatment are becoming a part of the center for stakeholders in this sector. This will present lucrative opportunities during the forecast period.

Furthermore, the Covid-19 pandemic has formed a positive impact on the leukapheresis industry. The enduring clinical trials for making COVID-19 vaccines can influence positively the leukapheresis products industry, as the study of white blood cells is essential in supporting vaccine growth.

Global Leukapheresis Market: Segmentation

The global leukapheresis market has been categorized into product type, application, and end-user. On the basis of the type of product, the global market has been segmented into leukapheresis disposables and leukapheresis devices. Based on the application, the global market has been divided into research applications and therapeutic applications. In terms of the end-user industry, the global leukapheresis market has been separated into blood component providers and blood centers, pharmaceutical and biotechnology companies, academic and research institutes, and hospital and transfusion centers.

Global Leukapheresis Market: Regional Analysis

On the basis of geography, the global leukapheresis market is classified into North America, Europe, Asia-Pacific, and the Rest of the World. The North American region is expected to witness a major growth rate in the global leukapheresis market over the estimated period. The key factors responsible for the market growth in the region of North America are the growing occurrence of blood cancer and the occurrence of the huge number of foremost biotechnology companies in the region. The Asia-Pacific market is expected to go up at the highest growth rate in the global leukapheresis market in the upcoming years owing to the promising markets in the region that becomes major growth hotspots in the industry because of the rising prevalence of leukemia, the mounting elderly population, the development in healthcare infrastructure, the escalating public and private investments for the advancement of CAR-T therapy, and the growing amount of clinical trials in China.

Global Leukapheresis Market: Competitive Players

Major market players operating in the global leukapheresis market include Asahi Kasei Medical Co. Ltd., Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo BCT Inc., Miltenyi Biotec, Macopharma SA, Guangzhou Daji Medical Science and Technology Co. Ltd., PuriBlood Medical Co. Ltd., MEDICA S.p.A, and Beijing ZKSK Technology Co. Ltd.

Global Leukapheresis Market: By Product Type

  • Leukapheresis Disposables
  • Leukapheresis Devices

Global Leukapheresis Market: By Application

  • Research Applications
  • Therapeutic Applications

Global Leukapheresis Market: By End-User

  • Blood Component Providers and Blood Centers
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Hospital and Transfusion Centers

Global Leukapheresis Market: Regional Segmentation Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

 

Frequently Asked Questions

What are the key factors driving global leukapheresis market expansion?

Significant factors fuelling the growth of the global leukapheresis market are the growing occurrence and prevalence of leukemia and the increasing demand for leukopaks for research applications.

What will be the value of the leukapheresis market during 2021 - 2026?

Global demand for the leukapheresis market was estimated at approximately USD 94.7 Million in 2020 and is expected to generate revenue of around USD 580.1 Million by the end of 2026, growing at a CAGR of around 38.6% between 2021 and 2026.

Which region will make notable contributions towards global leukapheresis market revenue?

The North American region is expected to witness a major growth rate in the global leukapheresis market over the estimated period. The key factors responsible for the market growth in the region of North America are the growing occurrence of blood cancer and the occurrence of the huge number of foremost biotechnology companies in the region.

What are the key players leveraging leukapheresis market growth?

Major market players operating in the global leukapheresis market include Asahi Kasei Medical Co. Ltd., Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo BCT Inc., Miltenyi Biotec, Macopharma SA, Guangzhou Daji Medical Science and Technology Co. Ltd., PuriBlood Medical Co. Ltd., MEDICA S.p.A, and Beijing ZKSK Technology Co. Ltd.

 

Table Of Content

  • Chapter 1 Executive Summary
    • 1.1. Introduction of Leukapheresis
    • 1.2. Global Leukapheresis Market, 2020 & 2026 (USD Million)
    • 1.3. Global Leukapheresis Market, 2016 – 2026(USD Million)
    • 1.4. Global Leukapheresis MarketAbsulute Revenue Opportunity, 2016 – 2026(USD Million)
    • 1.5. Global Leukapheresis MarketIncremental Revenue Opportunity, 2020 – 2026(USD Million)
  • Chapter 2 Leukapheresis Market – Product Type Analysis
    • 2.1. Global Leukapheresis Market – Product Type Overview
    • 2.2. Global Leukapheresis Market Share, by Product Type, 2020 & 2026(USD Million)
    • 2.3. Leukapheresis Disposables
      • 2.3.1. Global Leukapheresis Disposables Leukapheresis Market, 2016 – 2026(USD Million)
    • 2.4. Leukapheresis Devices
      • 2.4.1. Global Leukapheresis Devices Leukapheresis Market, 2016 – 2026(USD Million)
  • Chapter 3 Leukapheresis Market – Application Analysis
    • 3.1. Global Leukapheresis Market – Application Overview
    • 3.2. Global Leukapheresis Market Share, by Application, 2020 & 2026(USD Million)
    • 3.3. Research Applications
      • 3.3.1. Global Research Applications Leukapheresis Market, 2016 – 2026(USD Million)
    • 3.4. Therapeutic Applications
      • 3.4.1. Global Therapeutic Applications Leukapheresis Market, 2016 – 2026(USD Million)
  • Chapter 4 Leukapheresis Market – End-User Analysis
    • 4.1. Global Leukapheresis Market – End-User Overview
    • 4.2. Global Leukapheresis Market Share, by End-User, 2020 & 2026(USD Million)
    • 4.3. Blood Component Providers and Blood Centers
      • 4.3.1. Global Blood Component Providers and Blood Centers Leukapheresis Market, 2016 – 2026(USD Million)
    • 4.4. Pharmaceutical and Biotechnulogy Companies
      • 4.4.1. Global Pharmaceutical and Biotechnulogy Companies Leukapheresis Market, 2016 – 2026(USD Million)
    • 4.5. Academic and Research Institutes
      • 4.5.1. Global Academic and Research Institutes Leukapheresis Market, 2016 – 2026(USD Million)
    • 4.6. Hospital and Transfusion Centers
      • 4.6.1. Global Hospital and Transfusion Centers Leukapheresis Market, 2016 – 2026(USD Million)
  • Chapter 5 Leukapheresis Market – Regional Analysis
    • 5.1. Global Leukapheresis Market Regional Overview
    • 5.2. Global Leukapheresis Market Share, by Region, 2020 & 2026(USD Million)
    • 5.3. North America
      • 5.3.1. North America Leukapheresis Market, 2016 – 2026(USD Million)
        • 5.3.1.1. North America Leukapheresis Market, by Country, 2016 - 2026(USD Million)
      • 5.3.2. North America Leukapheresis Market, by Product Type, 2016 – 2026
        • 5.3.2.1. North America Leukapheresis Market, by Product Type, 2016 – 2026(USD Million)
      • 5.3.3. North America Leukapheresis Market, by Application, 2016 – 2026
        • 5.3.3.1. North America Leukapheresis Market, by Application, 2016 – 2026(USD Million)
      • 5.3.4. North America Leukapheresis Market, by End-User, 2016 – 2026
        • 5.3.4.1. North America Leukapheresis Market, by End-User, 2016 – 2026(USD Million)
      • 5.3.5. U.S.
        • 5.3.5.1. U.S. Leukapheresis Market, 2016 – 2026(USD Million)
      • 5.3.6. Canada
        • 5.3.6.1. Canada Leukapheresis Market, 2016 – 2026(USD Million)
    • 5.4. Europe
      • 5.4.1. Europe Leukapheresis Market, 2016 – 2026(USD Million)
        • 5.4.1.1. Europe Leukapheresis Market, by Country, 2016 - 2026(USD Million)
      • 5.4.2. Europe Leukapheresis Market, by Product Type, 2016 – 2026
        • 5.4.2.1. Europe Leukapheresis Market, by Product Type, 2016 – 2026(USD Million)
      • 5.4.3. Europe Leukapheresis Market, by Application, 2016 – 2026
        • 5.4.3.1. Europe Leukapheresis Market, by Application, 2016 – 2026(USD Million)
      • 5.4.4. Europe Leukapheresis Market, by End-User, 2016 – 2026
        • 5.4.4.1. Europe Leukapheresis Market, by End-User, 2016 – 2026(USD Million)
      • 5.4.5. Germany
        • 5.4.5.1. Germany Leukapheresis Market, 2016 – 2026(USD Million)
      • 5.4.6. France
        • 5.4.6.1. France Leukapheresis Market, 2016 – 2026(USD Million)
      • 5.4.7. U.K.
        • 5.4.7.1. U.K. Leukapheresis Market, 2016 – 2026(USD Million)
      • 5.4.8. Italy
        • 5.4.8.1. Italy Leukapheresis Market, 2016 – 2026(USD Million)
      • 5.4.9. Spain
        • 5.4.9.1. Spain Leukapheresis Market, 2016 – 2026(USD Million)
      • 5.4.10. Rest of Europe
        • 5.4.10.1. Rest of Europe Leukapheresis Market, 2016 – 2026(USD Million)
    • 5.5. Asia Pacific
      • 5.5.1. Asia Pacific Leukapheresis Market, 2016 – 2026(USD Million)
        • 5.5.1.1. Asia Pacific Leukapheresis Market, by Country, 2016 - 2026(USD Million)
      • 5.5.2. Asia Pacific Leukapheresis Market, by Product Type, 2016 – 2026
        • 5.5.2.1. Asia Pacific Leukapheresis Market, by Product Type, 2016 – 2026(USD Million)
      • 5.5.3. Asia Pacific Leukapheresis Market, by Application, 2016 – 2026
        • 5.5.3.1. Asia Pacific Leukapheresis Market, by Application, 2016 – 2026(USD Million)
      • 5.5.4. Asia Pacific Leukapheresis Market, by End-User, 2016 – 2026
        • 5.5.4.1. Asia Pacific Leukapheresis Market, by End-User, 2016 – 2026(USD Million)
      • 5.5.5. China
        • 5.5.5.1. China Leukapheresis Market, 2016 – 2026(USD Million)
      • 5.5.6. Japan
        • 5.5.6.1. Japan Leukapheresis Market, 2016 – 2026(USD Million)
      • 5.5.7. India
        • 5.5.7.1. India Leukapheresis Market, 2016 – 2026(USD Million)
      • 5.5.8. South Korea
        • 5.5.8.1. South Korea Leukapheresis Market, 2016 – 2026(USD Million)
      • 5.5.9. South-East Asia
        • 5.5.9.1. South-East Asia Leukapheresis Market, 2016 – 2026(USD Million)
      • 5.5.10. Rest of Asia Pacific
        • 5.5.10.1. Rest of Asia Pacific Leukapheresis Market, 2016 – 2026(USD Million)
    • 5.6. Latin America
      • 5.6.1. Latin America Leukapheresis Market, 2016 – 2026(USD Million)
        • 5.6.1.1. Latin America Leukapheresis Market, by Country, 2016 - 2026(USD Million)
      • 5.6.2. Latin America Leukapheresis Market, by Product Type, 2016 – 2026
        • 5.6.2.1. Latin America Leukapheresis Market, by Product Type, 2016 – 2026(USD Million)
      • 5.6.3. Latin America Leukapheresis Market, by Application, 2016 – 2026
        • 5.6.3.1. Latin America Leukapheresis Market, by Application, 2016 – 2026(USD Million)
      • 5.6.4. Latin America Leukapheresis Market, by End-User, 2016 – 2026
        • 5.6.4.1. Latin America Leukapheresis Market, by End-User, 2016 – 2026(USD Million)
      • 5.6.5. Brazil
        • 5.6.5.1. Brazil Leukapheresis Market, 2016 – 2026(USD Million)
      • 5.6.6. Mexico
        • 5.6.6.1. Mexico Leukapheresis Market, 2016 – 2026(USD Million)
      • 5.6.7. Rest of Latin America
        • 5.6.7.1. Rest of Latin America Leukapheresis Market, 2016 – 2026(USD Million)
    • 5.7. The Middle-East and Africa
      • 5.7.1. The Middle-East and Africa Leukapheresis Market, 2016 – 2026(USD Million)
        • 5.7.1.1. The Middle-East and Africa Leukapheresis Market, by Country, 2016 - 2026(USD Million)
      • 5.7.2. The Middle-East and Africa Leukapheresis Market, by Product Type, 2016 – 2026
        • 5.7.2.1. The Middle-East and Africa Leukapheresis Market, by Product Type, 2016 – 2026(USD Million)
      • 5.7.3. The Middle-East and Africa Leukapheresis Market, by Application, 2016 – 2026
        • 5.7.3.1. The Middle-East and Africa Leukapheresis Market, by Application, 2016 – 2026(USD Million)
      • 5.7.4. The Middle-East and Africa Leukapheresis Market, by End-User, 2016 – 2026
        • 5.7.4.1. The Middle-East and Africa Leukapheresis Market, by End-User, 2016 – 2026(USD Million)
      • 5.7.5. GCC Countries
        • 5.7.5.1. GCC Countries Leukapheresis Market, 2016 – 2026(USD Million)
      • 5.7.6. South Africa
        • 5.7.6.1. South Africa Leukapheresis Market, 2016 – 2026(USD Million)
      • 5.7.7. Rest of Middle-East Africa
        • 5.7.7.1. Rest of Middle-East Africa Leukapheresis Market, 2016 – 2026(USD Million)
  • Chapter 6 Leukapheresis Market – Competitive Landscape
    • 6.1. Competitor Market Share – Revenue
    • 6.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    • 6.3. Strategic Developments
      • 6.3.1. Acquisitions and Mergers
      • 6.3.2. New Products
      • 6.3.3. Research & Development Activities
  • Chapter 7 Company Profiles
    • 7.1. Asahi Kasei Medical Co. Ltd.
      • 7.1.1. Company Overview
      • 7.1.2. Product/ServicePortfulio
      • 7.1.3. Asahi Kasei Medical Co. Ltd. Sales, Revenue, and Gross Margin
      • 7.1.4. Asahi Kasei Medical Co. Ltd. Revenue and Growth Rate
      • 7.1.5. Asahi Kasei Medical Co. Ltd. Market Share
      • 7.1.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.2. Haemonetics Corporation
      • 7.2.1. Company Overview
      • 7.2.2. Product/ServicePortfulio
      • 7.2.3. Haemonetics Corporation Sales, Revenue, and Gross Margin
      • 7.2.4. Haemonetics Corporation Revenue and Growth Rate
      • 7.2.5. Haemonetics Corporation Market Share
      • 7.2.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.3. Fresenius SE & Co. KGaA
      • 7.3.1. Company Overview
      • 7.3.2. Product/ServicePortfulio
      • 7.3.3. Fresenius SE & Co. KGaA Sales, Revenue, and Gross Margin
      • 7.3.4. Fresenius SE & Co. KGaA Revenue and Growth Rate
      • 7.3.5. Fresenius SE & Co. KGaA Market Share
      • 7.3.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.4. Terumo BCT Inc.
      • 7.4.1. Company Overview
      • 7.4.2. Product/ServicePortfulio
      • 7.4.3. Terumo BCT Inc. Sales, Revenue, and Gross Margin
      • 7.4.4. Terumo BCT Inc. Revenue and Growth Rate
      • 7.4.5. Terumo BCT Inc. Market Share
      • 7.4.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.5. Miltenyi Biotec
      • 7.5.1. Company Overview
      • 7.5.2. Product/ServicePortfulio
      • 7.5.3. Miltenyi Biotec Sales, Revenue, and Gross Margin
      • 7.5.4. Miltenyi Biotec Revenue and Growth Rate
      • 7.5.5. Miltenyi Biotec Market Share
      • 7.5.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.6. Macopharma SA
      • 7.6.1. Company Overview
      • 7.6.2. Product/ServicePortfulio
      • 7.6.3. Macopharma SA Sales, Revenue, and Gross Margin
      • 7.6.4. Macopharma SA Revenue and Growth Rate
      • 7.6.5. Macopharma SA Market Share
      • 7.6.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.7. Guangzhou Daji Medical Science and Technulogy Co. Ltd.
      • 7.7.1. Company Overview
      • 7.7.2. Product/ServicePortfulio
      • 7.7.3. Guangzhou Daji Medical Science and Technulogy Co. Ltd. Sales, Revenue, and Gross Margin
      • 7.7.4. Guangzhou Daji Medical Science and Technulogy Co. Ltd. Revenue and Growth Rate
      • 7.7.5. Guangzhou Daji Medical Science and Technulogy Co. Ltd. Market Share
      • 7.7.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.8. PuriBlood Medical Co. Ltd.
      • 7.8.1. Company Overview
      • 7.8.2. Product/ServicePortfulio
      • 7.8.3. PuriBlood Medical Co. Ltd. Sales, Revenue, and Gross Margin
      • 7.8.4. PuriBlood Medical Co. Ltd. Revenue and Growth Rate
      • 7.8.5. PuriBlood Medical Co. Ltd. Market Share
      • 7.8.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.9. MEDICA S.p.A
      • 7.9.1. Company Overview
      • 7.9.2. Product/ServicePortfulio
      • 7.9.3. MEDICA S.p.A Sales, Revenue, and Gross Margin
      • 7.9.4. MEDICA S.p.A Revenue and Growth Rate
      • 7.9.5. MEDICA S.p.A Market Share
      • 7.9.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 7.10. Beijing ZKSK Technulogy Co. Ltd.
      • 7.10.1. Company Overview
      • 7.10.2. Product/ServicePortfulio
      • 7.10.3. Beijing ZKSK Technulogy Co. Ltd. Sales, Revenue, and Gross Margin
      • 7.10.4. Beijing ZKSK Technulogy Co. Ltd. Revenue and Growth Rate
      • 7.10.5. Beijing ZKSK Technulogy Co. Ltd. Market Share
      • 7.10.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
  • Chapter 8 Leukapheresis — Industry Analysis
    • 8.1. Introduction and Taxonomy
    • 8.2. Leukapheresis Market – Key Trends
      • 8.2.1. Market Drivers
      • 8.2.2. Market Restraints
      • 8.2.3. Market Opportunities
    • 8.3. Value Chain Analysis
    • 8.4. Key Mandates and Regulations
    • 8.5. Technulogy Roadmap and Timeline
    • 8.6. Leukapheresis Market – Attractiveness Analysis
      • 8.6.1. By Product Type
      • 8.6.2. By Application
      • 8.6.3. By End-User
      • 8.6.4. By Region
  • Chapter 9 Industrial Chain, Sourcing Strategy, and Downstream Buyers
    • 9.1. Leukapheresis Industrial Chain Analysis
    • 9.2. Downstream Buyers
    • 9.3. Distributors/Traders List
  • Chapter 10 Marketing Strategy Analysis
    • 10.1. Marketing Channel
    • 10.2. Direct Marketing
    • 10.3. Indirect Marketing
    • 10.4. Marketing Channel Development Trends
    • 10.5. Economic/Pulitical Environmental Change
  • Chapter 11 Report Conclusion& Key Insights
    • 11.1. Key Insights from Primary Interviews & Surveys Respondents
    • 11.2. Key Takeaways from Analysts, Consultants, and Industry Leaders
  • Chapter 12 Research Approach & Methodulogy
    • 12.1. Report Description
    • 12.2. Research Scope
    • 12.3. Research Methodulogy
      • 12.3.1. Secondary Research
      • 12.3.2. Primary Research
      • 12.3.3. Statistical Models
        • 12.3.3.1. Company Share Analysis Model
        • 12.3.3.2. Revenue Based Modeling
      • 12.3.4. Research Limitations

Inquiry For Buying

Leukapheresis

Please fill out the form. We will contact you within 24 hours:
All fields required...

Request Sample

Leukapheresis

Please fill out the form. We will contact you within 24 hours:
All fields required...
Inquiry For Buying

×

Avail Free PDF Sample Report

This website is secure and your personal details are safe. Privacy Policy

Thank you for contacting us.

Thank you for your interest in our research report.

We will be sending you the sample copy of the report shortly. Meanwhile, if you have any specific research requirement then please let us know. We will be glad to assist you in case you have any additional questions, so feel free to get in touch

Thank you


Warm regards,
Sales | Manager - International Business and partner Relations
Direct line: +1 347 535 0815
Market Research Store
E-mail: sales@MarketResearchStore.com | Web: www.MarketResearchStore.com